Demonstrating PQS Effectiveness and Driving Continual Improvement: Evidence-Based Risk Reduction
E Ramnarine, K O'Donnell - PDA Journal of Pharmaceutical …, 2018 - journal.pda.org
Product knowledge grows and evolves during the life of a product. In order to maintain a
state of control and deliver product with consistent quality throughout its commercial life …
state of control and deliver product with consistent quality throughout its commercial life …
PDA points to consider: technical product lifecycle management. Pharmaceutical quality system effectiveness for managing post-approval changes
E Ramnarine, U Busse, M Colao… - PDA Journal of …, 2017 - journal.pda.org
Background During the commercial manufacturing phase of the product lifecycle, specific
elements of the PQS are used to identify and manage PACs. Per ICH Q10, these include …
elements of the PQS are used to identify and manage PACs. Per ICH Q10, these include …
Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS)-Through Enhanced Science and Risk-Based Approaches Industry One …
E Ramnarine, A Vinther, K Bruhin, C Tovar… - PDA Journal of …, 2020 - journal.pda.org
Post-approval changes are inevitable and necessary throughout the life of a drug product−
to implement new knowledge, maintain a state of control, and drive continual improvement …
to implement new knowledge, maintain a state of control, and drive continual improvement …
Industry One-Voice-of-Quality (1VQ) Solutions: Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS)—through Enhanced …
E Ramnarine, A Vinther, K Bruhin, C Tovar… - PDA Journal of …, 2020 - journal.pda.org
Post-approval changes are inevitable and necessary throughout the life of a drug product—
to implement new knowledge, maintain a state of control, and drive continual improvement …
to implement new knowledge, maintain a state of control, and drive continual improvement …
Industry one-voice-of-quality solutions management review of post-approval changes guide
A Vinther, F Mohammed… - PDA Journal of …, 2021 - journal.pda.org
Post-approval changes (PACs) are inevitable and necessary throughout the life of a drug
product. Because many PACs require prior approval by individual regulatory agencies each …
product. Because many PACs require prior approval by individual regulatory agencies each …
[HTML][HTML] Quality Risk Management 101: A Brief History Of Risk Management In The Regulation Of Medicinal Products
K Waldron - 2021 - pharmaceuticalonline.com
This article is the second in a series of six articles intended to provide a holistic primer on the
field of quality risk management (QRM). The first article, Quality Risk Management 101 …
field of quality risk management (QRM). The first article, Quality Risk Management 101 …
[PDF][PDF] IMPLEMENTATION OF QUALITY RISK MANAGEMENT (QRM) IN PHARMACEUTICAL INDUSRTY: A REVIEW
R Suryawanshi⃰, A Mohalkar, R Jadhav… - 2015 - wjpr.s3.ap-south-1.amazonaws.com
ABSTRACT The purpose of Quality Risk Management is to illustrate practical ways to
analyze the risks to quality system, providing guidance along the way to achieving effective …
analyze the risks to quality system, providing guidance along the way to achieving effective …
ICH Q9 quality risk management
D Elder, A Teasdale - ICH quality guidelines: an …, 2017 - Wiley Online Library
Summary International Conference on Harmonisation (ICH) Q9 focuses on the behaviors of
industry and the regulatory authorities on the primary principles of quality risk management …
industry and the regulatory authorities on the primary principles of quality risk management …
[HTML][HTML] Does quality risk management add value?
H Johanning, A Dahlgaard - Pharmaceutical Technology Europe, 2007 - pharmtech.com
It is becoming evident that quality risk management within regulated, life sciences
environments is a valuable component of an effective quality management system (QMS). A …
environments is a valuable component of an effective quality management system (QMS). A …
2015/2016 Quality Risk Management Benchmarking Survey
K Waldron, E Ramnarine, J Hartman - PDA Journal of …, 2017 - journal.pda.org
This paper investigates the concept of quality risk management (QRM) maturity as it applies
to the pharmaceutical and biopharmaceutical industries, using the results and analysis from …
to the pharmaceutical and biopharmaceutical industries, using the results and analysis from …